They proposed that serum BDNF can be a useful prognostic biomarker to predict adverse clinical outcomes in patients with HF.Besides, decreased serum BDNF levels are correlated with exercise intolerance in patients with HF [66]. The gene discussed is BDNF; the disease is hydrops fetalis.